Today, May 15, 2017, the Board of Directors of Emotra AB (“Emotra”) announced that the Company’s management team has been busy during the weeks since our consensus meeting in Rome and the EPA conference in Florence preparing the market introduction of EDOR®. The...
The Board and CEO of Emotra AB (publ) hereby present the interim report for the first quarter 2017. 170426- Interim report Jan-Mar 2017_EN
The Board of Directors of Emotra AB (Emotra) is hereby serving notice for an extraordinary shareholder meeting to be held on May 19, 2017. This meeting is being held to vote on a resolution to grant the Board the authority to carry out a new share issue with right of...
Notice is hereby given that an extraordinary general meeting of shareholders in Emotra AB (publ), 556612-1579, will be held at 12 noon on Friday May 19, 2017 at the restaurant John Scott´s Pub, at 15 Kungsportsavenyn in Göteborg, Sweden. 170503 - Emotra -...
Emotra’s management team has just returned from several days of hard work and successes in connection with the EPA’s conference in Florence, Italy. Researchers from a number of countries have reached out to congratulate us on our successfully concluded study and to...
The Emotra clinical multicentre study, EUDOR-A, which was started during the spring of 2014, has been finalized. The study clearly demonstrates a lower number of suicides in comparison with previous studies, particularly and statistically significantly in the...
The European Commission, EC, has rejected Emotra’s application, submitted in January 2017, for approximately 3 MEUR, intended for three purposes: First of all to finance EUDOR-Y, a clinical multi-centre study on young people, secondly to develop EDOR® Interconnect,...
The Board and CEO of Emotra AB herewith present the year-end report for the financial year 2016. 170215 - Year-end report 2016
Emotra has submitted a new application to the European Commission (EC) for Horizon 2020 funding assistance. The Company’s previous application, which we submitted in October 2016, cleared the threshold by a wide margin and was awarded a “Seal of Excellence” by the EC....
On November 28, Emotra announced that the Company’s Horizon 2020 application to the European Commission has been rejected. We have now had the opportunity to review the EC’s statement and we see that our application passed their threshold by a wide margin and that it...
